Literature DB >> 9039987

Molecular analysis of patients of Sardinian descent with Crigler-Najjar syndrome type I.

M C Rosatelli1, A Meloni, V Faa, L Saba, G Crisponi, M G Clemente, G Meloni, M T Piga, A Cao.   

Abstract

This study reports the molecular characterisation of the bilirubin UDP-glucuronosyl-transferase gene (UGT1) in a group of patients of Sardinian descent with Crigler-Najjar syndrome type I and their relatives. Sequence analysis of both UGT1A exon 1 and common exons 2-5 was performed in all patients, leading to the detection of AF170 and a novel mutation (470insT), both residing in UGT1A exon 1. All but two heterozygotes for the AF170 mutation showed normal serum bilirubin levels. These two subjects were also heterozygous for the sequence variation A(TA)7TAA in the promoter region of the UGT1A gene.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9039987      PMCID: PMC1050864          DOI: 10.1136/jmg.34.2.122

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  14 in total

1.  Congenital familial nonhemolytic jaundice with kernicterus.

Authors:  J F CRIGLER; V A NAJJAR
Journal:  Pediatrics       Date:  1952-08       Impact factor: 7.124

2.  Identification of an A-to-G missense mutation in exon 2 of the UGT1 gene complex that causes Crigler-Najjar syndrome type 2.

Authors:  N Moghrabi; D J Clarke; M Boxer; B Burchell
Journal:  Genomics       Date:  1993-10       Impact factor: 5.736

3.  A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini.

Authors:  J K Ritter; F Chen; Y Y Sheen; H M Tran; S Kimura; M T Yeatman; I S Owens
Journal:  J Biol Chem       Date:  1992-02-15       Impact factor: 5.157

4.  Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert's syndrome.

Authors:  S Aono; Y Adachi; E Uyama; Y Yamada; H Keino; T Nanno; O Koiwai; H Sato
Journal:  Lancet       Date:  1995-04-15       Impact factor: 79.321

5.  Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man.

Authors:  P J Bosma; J Seppen; B Goldhoorn; C Bakker; R P Oude Elferink; J R Chowdhury; N R Chowdhury; P L Jansen
Journal:  J Biol Chem       Date:  1994-07-08       Impact factor: 5.157

6.  Altered coding for a strictly conserved di-glycine in the major bilirubin UDP-glucuronosyltransferase of a Crigler-Najjar type I patient.

Authors:  M Ciotti; M T Yeatman; R J Sokol; I S Owens
Journal:  J Biol Chem       Date:  1995-02-17       Impact factor: 5.157

7.  Cloning of two human liver bilirubin UDP-glucuronosyltransferase cDNAs with expression in COS-1 cells.

Authors:  J K Ritter; J M Crawford; I S Owens
Journal:  J Biol Chem       Date:  1991-01-15       Impact factor: 5.157

8.  Identification of defect in the genes for bilirubin UDP-glucuronosyl-transferase in a patient with Crigler-Najjar syndrome type II.

Authors:  S Aono; Y Yamada; H Keino; N Hanada; T Nakagawa; Y Sasaoka; T Yazawa; H Sato; O Koiwai
Journal:  Biochem Biophys Res Commun       Date:  1993-12-30       Impact factor: 3.575

9.  A mutation in bilirubin uridine 5'-diphosphate-glucuronosyltransferase isoform 1 causing Crigler-Najjar syndrome type II.

Authors:  P J Bosma; B Goldhoorn; R P Oude Elferink; M Sinaasappel; B A Oostra; P L Jansen
Journal:  Gastroenterology       Date:  1993-07       Impact factor: 22.682

10.  The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.

Authors:  P J Bosma; J R Chowdhury; C Bakker; S Gantla; A de Boer; B A Oostra; D Lindhout; G N Tytgat; P L Jansen; R P Oude Elferink
Journal:  N Engl J Med       Date:  1995-11-02       Impact factor: 91.245

View more
  1 in total

1.  Novel combined UGT1A1 mutations in Crigler Najjar Syndrome type I.

Authors:  Nawel Abdellaoui; Balkiss Abdelmoula; Rania Abdelhedi; Najla Kharrat; Mouna Tabebi; Ahmed Rebai; Nouha Bouayed Abdelmoula
Journal:  J Clin Lab Anal       Date:  2022-05-09       Impact factor: 3.124

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.